| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74c798427f01c9817c7580a811ab5241 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00 |
| filingDate |
2005-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbca3f2ffdf2a0caa85c69fa917e4bcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36154e0814250a4df2332ec2b23e2a7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e13e509c555ec6bb18501c222053433a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_287d879461c1025ebcfe616f4ff5fe5c |
| publicationDate |
2009-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2369408-C2 |
| titleOfInvention |
Hemostatic composition comprising hyaluronic acid |
| abstract |
FIELD: medicine. n SUBSTANCE: according to the invention there is provided a hemostatic composition comprising gelatin and hyaluronic acid or its derivative, wherein the specified hyaluronic acid or its derivative is included in the specified composition with final content of at least 10% (wt/wt) and/or wherein the specified hyaluronic acid or its derivative is cross-linked by the exposure to dry heat at a temperature of 110°C to 200°C. According to the invention, there are provided methods of obtaining the said compositions and their application. n EFFECT: invention ensures reduced swelling, which allows safer sponge application, improved hemostatic properties and improved adhesive properties decreasing therethrough post-operation tissue bond. n 74 cl, 8 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2611046-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10022410-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10022411-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2581918-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2710224-C1 |
| priorityDate |
2004-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |